Activation of the oncogenic potential of ras oncogenes occurs by point mutations at codons 12, 13, 59, 61, and 63 of the sequences that codify for its product, a 21-kDa protein designated as p21. This activation has been postulated by computer models as modifiers of the structure of the protein, which may alter its biochemical and biological activities. We have expressed in bacteria the normal ras p21 and five mutated p21 proteins with mutations at positions 12, 59, 61, 12 plus 59, and 12 plus 61. Purification was carried out by solubilization from bacterial pellets in 7 M urea and chromatography through a Sephadex G-100 column to obtain > 95% purified proteins. Circular dichroic (CD) spectra showed that the normal protein and that activated by substitution of Alas' to Thr5' are very similar in their overall structure. By contrast, point mutations affecting either 12 or 61 residues substantially altered the structure of the proteins. When the parameters of Chen et al. [Biochemistry 11, 4120-4131 (1972)l were applied to the CD spectra, both normal and thr5'-mutated ras proteins showed a less organized structure than mutated proteins at position 12 or 61. Since the Thr5' mutant has a more similar transforming activity than other activated proteins, but a GTPase activity similar to that of the normal protein, our results support the hypothesis that there is more than one mechanism of activation of the ras p21 protein.One of these mechanisms involves important structural alterations by point mutations at position 12 or 61 which reduce the GTPase activity of the protein. Another mechanism will be that induced by a substitution of Ala5' to Thr59 which does not substantially alter the protein conformation. A putative alternative mechanism for the activation of this mutant is discussed.The p21 product of the ras oncogene has been related to the production of tumors in man and animals [l -31. Point mutations within the coding sequence of the normal genes at positions 12,13,59,61, or 63 [4-81 alter the biological activity of the protein, inducing a transforming 21-kDa product, p21. However, it is still unknown how such point mutations, which alter the p21 sequence, can affect the normal function of the protein.The rczs p21 proteins have GDP/GTP-binding properties [9, 103, hydrolyze GTP 113-141 and when Thr is at position 59, they show a GTP-dependent, autophosphorylation activity [15]. Point mutations that affect the transforming activity of the protein at position 12, 59, or 61, do not substantially modify its ability to bind GDP or GTP or its location at the plasma membrane [16]. However, point mutations at positions 12 or 61, but not at 59, reduce the GTPase activity of the protein by 5-10-fold 111 -141.Recently, it has been suggested that a reduction of the GTPase activity of the ras p21 protein is not a good estimate of its transforming potential. Proteins with substitution of Ala5' to Thr5' show a GTPase activity comparable to the normal counterpart but are efficient transforming proteins [14]. Moreover, a reduction...